Current Oncology, Volume 20, Issue 6

Today, most oncologists would agree that Anderson’s statement is common sense and subscribe to its expressed wisdom. [...]

Background: After treatment, patients with active cancer face a considerable burden from the effects of both the disease and its treatment. The Palliative Rehabilitation Program (PRP) is designed to ameliorate disease effects and to improve the patie...

Background: Cancer can affect many dimensions of a patient’s life, and in turn, it should be targeted using a multimodal approach. We tested the extent to which an interdisciplinary nutrition–rehabilitation program can improve the well-being of patie...

Objective: To be useful to policymakers and stakeholders, cost-effectiveness analyses (CEAS) should be published in a timely manner and without bias. The aims of the present study were to examine the time between conference abstract presentation and...

Background: The survival benefit for single-agent anti–epidermal growth factor receptor (EGFR) therapy compared with combination therapy with irinotecan in KRAS wildtype (wt) metastatic colorectal cancer (mCRC) patients in the third-line treatment se...

Purpose: Imaging by fluorodeoxyglucose positron-emission tomography (PET) has emerged as a valuable tool in the management of locally advanced cervical cancer (LACC), both for assessment of lymph node status and determination of response to chemoradi...

Background: Healthy lifestyle behaviours may improve outcomes for people with colorectal cancer (CRC), but the intention to take action and to change those behaviours may vary with time and resource availability. We aimed to estimate the prevalence o...

Health services researchers have consistently identified a gap between what is identified as “best practice” and what actually happens in clinical care. Despite nearly two decades of a growing evidence-based practice movement, narrowing the knowledge...

Background: Prostate cancer (pca) is the most common non-skin cancer among men in Canada and other Western countries. Increased prevalence and higher cost of newer treatments have led to a significant rise in the economic burden of pca. The objective...

Background: Patients with cancer are often treated with glucocorticoids (GCS) as part of therapy, which may cause hyperglycemia. We sought to define the prevalence of, and risk factors for, hyperglycemia in this setting. Methods: Adult patients takin...